Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections)
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 147 (1-2) , 43-49
- https://doi.org/10.1016/j.jneuroim.2003.10.013
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- APOE genotype-specific differences in human and mouse macrophage nitric oxide productionJournal of Neuroimmunology, 2004
- Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic miceJournal of Neuroimmunology, 2002
- APP knockout attenuates microglial activation and enhances neuron survival in substantia nigra compacta after axotomyGlia, 2002
- Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptideTrends in Molecular Medicine, 2001
- Costimulatory Effects of Interferon-γ and Interleukin-1β or Tumor Necrosis Factor α on the Synthesis of Aβ1-40 and Aβ1-42 by Human AstrocytesNeurobiology of Disease, 2000
- Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's diseaseNeuroscience, 1999
- TNFα plus IFNγ induce the production of Alzheimer β‐amyloid peptides and decrease the secretion of APPsThe FASEB Journal, 1999
- Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugsNeurobiology of Aging, 1995
- Transforming growth factor-β protects human neurons against β-amyloid-induced injuryMolecular and Chemical Neuropathology, 1994
- Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseNeuroscience Letters, 1994